Gouvernance Theraclion Deutsche Boerse AG

941 FR0010120402

Equipement et technologie médicale avancés

Temps Différé Deutsche Boerse AG 08:01:30 26/08/2026			Varia. 5j.	Varia. 1 janv.
0,5940 ^EUR	-1,00%		-1,00%	-

09/07	Theraclion annonce des changements au sein de son conseil d'administration	CI
09/07	Vincent Gardès prend la présidence du conseil d'administration de Theraclion

Comité Exécutif: Theraclion

Dirigeant

Fonctions occupéesDepuis

Martin Deterre

Chief Executive Officer

24/05/2023

Michel Nuta

Chief Tech/Sci/R&D Officer

01/01/2013

Jeremie Anquez

Chief Tech/Sci/R&D Officer

Vivien Jourdannaud

General Counsel

Julie Veisseire

Director of Finance/CFO

Alexandra Rocher

Chief Operating Officer

Composition du Conseil d'Administration: Theraclion

Administrateur

ComitésDepuis

Vincent Gardès

Chairman

08/07/2026

Mehdi El Glaoui

Audit Committee
Compensation Committee Chair
Governance Committee Chair
Nominating Committee Chair

Claude Lenoir

75 ans

Director/Board Member

08/07/2026

Cédric Bellanger

Director/Board Member

28/01/2022

Lijuan Deng

Director/Board Member

29/06/2023

Anciens Dirigeants et Administrateurs: Theraclion

Insider

Fonctions occupées

DepuisJusqu'au

Xin Lin

Director/Board Member

29/06/2023

Yann Duchesne

Chairman

24/01/2022

Christopher S. Bödtker

Director/Board Member	01/04/2019	28/04/2020
Chairman	28/04/2020	11/12/2021

Shawn Langer

Director/Board Member

13/02/2019

Bernd von Polheim

Director/Board Member	20/12/2012	13/02/2019
Independent Dir/Board Member	20/12/2012	13/02/2019

Ari Kellen

Director/Board Member

13/02/2019

Sylvain Yon

Director/Board Member	-	13/02/2019
Chief Tech/Sci/R&D Officer	21/12/2009	31/12/2014
Corporate Officer/Principal	01/01/2009	-

Wolfram Eichner

Director/Board Member

12/05/2016

20/03/2018

François Lacoste

Director/Board Member	05/06/2012	01/02/2018
Chairman	21/12/2009	05/06/2012
Chief Tech/Sci/R&D Officer	21/12/2009	01/02/2018
Founder	21/12/2009	01/02/2018
President	05/08/2004	21/12/2009

Renaud Saleur

Director/Board Member

01/02/2018

Amit Kakar

Director/Board Member	23/03/2017	-
Independent Dir/Board Member	23/03/2017	-

Laurent Levy

Director/Board Member

12/05/2016

Samuel G. Levy

Director/Board Member

12/05/2016

Annette Hasenburg

Director/Board Member	20/12/2012	12/05/2016
Independent Dir/Board Member	20/12/2012	12/05/2016

Tilman B. Drueke

Director/Board Member	20/05/2010	12/05/2016
Independent Dir/Board Member	20/05/2010	12/05/2016

Lazlo Hegedüs

Director/Board Member	20/05/2010	12/05/2016
Independent Dir/Board Member	20/05/2010	12/05/2016

David Auregan

Chief Executive Officer	01/12/2015	24/05/2023
Director of Finance/CFO	01/12/2015	-
Investor Relations Contact	01/12/2015	-

Jose Abellan-Martinez

Sales & Marketing

01/01/2015

Stefano Vagliani

Chief Executive Officer

15/05/2013

David Caumartin

Chief Executive Officer

02/09/2014

Anja Kleber

Corporate Officer/Principal	-	-
Sales & Marketing	01/01/2014	-

Sarah Ankri

Chief Administrative Officer	01/01/2013	-
Director of Finance/CFO	01/01/2013	-
Investor Relations Contact	01/01/2013	-

Ismaël Nujurally

Director/Board Member	01/01/2007	21/12/2009
Chief Executive Officer	21/12/2009	01/01/2011

Jean-Yves Burel

Director/Board Member	28/04/2020	-
Chairman	20/05/2010	28/04/2020
President	20/05/2010	-

Philippe Pouletty

Director/Board Member

20/05/2010

David Del Bourgo

Corporate Officer/Principal	21/12/2009	05/06/2012
Sales & Marketing	05/06/2012	-

Roberta Brocardo

Chief Tech/Sci/R&D Officer

01/01/2007

Françoise Arnaud

Chief Tech/Sci/R&D Officer

01/12/2006

Jérôme Lebon

Founder

05/08/2004

01/01/2006

Christophe Lamboeuf

Director of Finance/CFO

Geoffrey Block

Director/Board Member

21/12/2009

Laurence Aucoin

Chief Operating Officer

Laurence Géricot

Director of Finance/CFO

Gaylord Tallec

Chief Operating Officer

Marie Berne

Sales & Marketing

Ling Ling Chea

Director of Finance/CFO

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	9
Femme	3

Dont comité exécutif

Homme	4
Femme	2

Dont Administrateurs

Homme	4
Femme	1

Theraclion est spécialisé dans le développement, la fabrication et la commercialisation d'équipements médicaux d'échothérapie associant thérapie par ultrasons focalisés (HIFU) et monitoring par échographie. La société propose l'Echopulse, un appareil destiné au traitement non-invasif et ambulatoire de l'adénofibrome du sein et des nodules thyroïdiens. Le CA par activité se répartit comme suit : - vente de consommables (52,8%) ; - vente d'équipements (28,8%) ; - prestations de services après-vente (18,4%). La grande majorité du CA est réalisée à l'international.

Employés

Secteur

Equipement et technologie médicale avancés

Agenda

14/10 Publication des résultats - Q2 2026

Plus d'informations sur la société